Hormone drugs are drugs that use human or animal hormones (including organic substances with the same structure and action principle as hormones) as active ingredients.
The global Hormonal Drugs market was valued at US$ 955.8 million in 2023 and is anticipated to reach US$ 220.2 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hormonal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Drugs.
Report Scope
The Hormonal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormonal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hormonal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Merck
Roche
Novartis
Mitsubishi Tanabe Pharma Korea
Anhui Renhe Pharmaceutical
Shanghai ZhongHua Pharmaceutical Nantong
He'nan Xuchang Huaren Pharmaceutical
Wuhan Wujing Pharmaceutical
Harbin Pharmaceutical Group
Changzhou Siyao Pharmaceuticals
Hunan Wzt Pharmaceutical
Tianjin Tianyao Pharmaceutical
Henan Lihua Pharmaceutical
Hubei Tiansheng Pharmaceutica
Shandong Xinhua Pharmaceutical
Huazhong Pharmaceutical
China Resources Zizhu Pharmaceutical
Shanghai CP GENERAL Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Segment by Type
Intravenous Injection
Take Orally
Topical
Others
Segment by Application
Hospital
Pharmacy
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hormonal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hormonal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Hormonal Drugs 麻豆原创 Overview
1.1 Product Overview and Scope of Hormonal Drugs
1.2 Hormonal Drugs Segment by Type
1.2.1 Global Hormonal Drugs 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Intravenous Injection
1.2.3 Take Orally
1.2.4 Topical
1.2.5 Others
1.3 Hormonal Drugs Segment by Application
1.3.1 Global Hormonal Drugs 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.4 Global Hormonal Drugs 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Hormonal Drugs Revenue 2019-2030
1.4.2 Global Hormonal Drugs Sales 2019-2030
1.4.3 Global Hormonal Drugs 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hormonal Drugs 麻豆原创 Competition by Manufacturers
2.1 Global Hormonal Drugs Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Hormonal Drugs Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Hormonal Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Hormonal Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hormonal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormonal Drugs, Product Type & Application
2.7 Hormonal Drugs 麻豆原创 Competitive Situation and Trends
2.7.1 Hormonal Drugs 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hormonal Drugs Players 麻豆原创 Share by Revenue
2.7.3 Global Hormonal Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hormonal Drugs Retrospective 麻豆原创 Scenario by Region
3.1 Global Hormonal Drugs 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hormonal Drugs Global Hormonal Drugs Sales by Region: 2019-2030
3.2.1 Global Hormonal Drugs Sales by Region: 2019-2024
3.2.2 Global Hormonal Drugs Sales by Region: 2025-2030
3.3 Global Hormonal Drugs Global Hormonal Drugs Revenue by Region: 2019-2030
3.3.1 Global Hormonal Drugs Revenue by Region: 2019-2024
3.3.2 Global Hormonal Drugs Revenue by Region: 2025-2030
3.4 North America Hormonal Drugs 麻豆原创 Facts & Figures by Country
3.4.1 North America Hormonal Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hormonal Drugs Sales by Country (2019-2030)
3.4.3 North America Hormonal Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hormonal Drugs 麻豆原创 Facts & Figures by Country
3.5.1 Europe Hormonal Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hormonal Drugs Sales by Country (2019-2030)
3.5.3 Europe Hormonal Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormonal Drugs 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Hormonal Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hormonal Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Hormonal Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hormonal Drugs 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Hormonal Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hormonal Drugs Sales by Country (2019-2030)
3.7.3 Latin America Hormonal Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormonal Drugs 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Hormonal Drugs 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hormonal Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hormonal Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hormonal Drugs Sales by Type (2019-2030)
4.1.1 Global Hormonal Drugs Sales by Type (2019-2024)
4.1.2 Global Hormonal Drugs Sales by Type (2025-2030)
4.1.3 Global Hormonal Drugs Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Hormonal Drugs Revenue by Type (2019-2030)
4.2.1 Global Hormonal Drugs Revenue by Type (2019-2024)
4.2.2 Global Hormonal Drugs Revenue by Type (2025-2030)
4.2.3 Global Hormonal Drugs Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Hormonal Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hormonal Drugs Sales by Application (2019-2030)
5.1.1 Global Hormonal Drugs Sales by Application (2019-2024)
5.1.2 Global Hormonal Drugs Sales by Application (2025-2030)
5.1.3 Global Hormonal Drugs Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Hormonal Drugs Revenue by Application (2019-2030)
5.2.1 Global Hormonal Drugs Revenue by Application (2019-2024)
5.2.2 Global Hormonal Drugs Revenue by Application (2025-2030)
5.2.3 Global Hormonal Drugs Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Hormonal Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Hormonal Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Hormonal Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Hormonal Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Mitsubishi Tanabe Pharma Korea
6.4.1 Mitsubishi Tanabe Pharma Korea Corporation Information
6.4.2 Mitsubishi Tanabe Pharma Korea Description and Business Overview
6.4.3 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Portfolio
6.4.5 Mitsubishi Tanabe Pharma Korea Recent Developments/Updates
6.5 Anhui Renhe Pharmaceutical
6.5.1 Anhui Renhe Pharmaceutical Corporation Information
6.5.2 Anhui Renhe Pharmaceutical Description and Business Overview
6.5.3 Anhui Renhe Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Anhui Renhe Pharmaceutical Hormonal Drugs Product Portfolio
6.5.5 Anhui Renhe Pharmaceutical Recent Developments/Updates
6.6 Shanghai ZhongHua Pharmaceutical Nantong
6.6.1 Shanghai ZhongHua Pharmaceutical Nantong Corporation Information
6.6.2 Shanghai ZhongHua Pharmaceutical Nantong Description and Business Overview
6.6.3 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Portfolio
6.6.5 Shanghai ZhongHua Pharmaceutical Nantong Recent Developments/Updates
6.7 He'nan Xuchang Huaren Pharmaceutical
6.6.1 He'nan Xuchang Huaren Pharmaceutical Corporation Information
6.6.2 He'nan Xuchang Huaren Pharmaceutical Description and Business Overview
6.6.3 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Portfolio
6.7.5 He'nan Xuchang Huaren Pharmaceutical Recent Developments/Updates
6.8 Wuhan Wujing Pharmaceutical
6.8.1 Wuhan Wujing Pharmaceutical Corporation Information
6.8.2 Wuhan Wujing Pharmaceutical Description and Business Overview
6.8.3 Wuhan Wujing Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wuhan Wujing Pharmaceutical Hormonal Drugs Product Portfolio
6.8.5 Wuhan Wujing Pharmaceutical Recent Developments/Updates
6.9 Harbin Pharmaceutical Group
6.9.1 Harbin Pharmaceutical Group Corporation Information
6.9.2 Harbin Pharmaceutical Group Description and Business Overview
6.9.3 Harbin Pharmaceutical Group Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Harbin Pharmaceutical Group Hormonal Drugs Product Portfolio
6.9.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.10 Changzhou Siyao Pharmaceuticals
6.10.1 Changzhou Siyao Pharmaceuticals Corporation Information
6.10.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
6.10.3 Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Portfolio
6.10.5 Changzhou Siyao Pharmaceuticals Recent Developments/Updates
6.11 Hunan Wzt Pharmaceutical
6.11.1 Hunan Wzt Pharmaceutical Corporation Information
6.11.2 Hunan Wzt Pharmaceutical Hormonal Drugs Description and Business Overview
6.11.3 Hunan Wzt Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hunan Wzt Pharmaceutical Hormonal Drugs Product Portfolio
6.11.5 Hunan Wzt Pharmaceutical Recent Developments/Updates
6.12 Tianjin Tianyao Pharmaceutical
6.12.1 Tianjin Tianyao Pharmaceutical Corporation Information
6.12.2 Tianjin Tianyao Pharmaceutical Hormonal Drugs Description and Business Overview
6.12.3 Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Portfolio
6.12.5 Tianjin Tianyao Pharmaceutical Recent Developments/Updates
6.13 Henan Lihua Pharmaceutical
6.13.1 Henan Lihua Pharmaceutical Corporation Information
6.13.2 Henan Lihua Pharmaceutical Hormonal Drugs Description and Business Overview
6.13.3 Henan Lihua Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Henan Lihua Pharmaceutical Hormonal Drugs Product Portfolio
6.13.5 Henan Lihua Pharmaceutical Recent Developments/Updates
6.14 Hubei Tiansheng Pharmaceutica
6.14.1 Hubei Tiansheng Pharmaceutica Corporation Information
6.14.2 Hubei Tiansheng Pharmaceutica Hormonal Drugs Description and Business Overview
6.14.3 Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Portfolio
6.14.5 Hubei Tiansheng Pharmaceutica Recent Developments/Updates
6.15 Shandong Xinhua Pharmaceutical
6.15.1 Shandong Xinhua Pharmaceutical Corporation Information
6.15.2 Shandong Xinhua Pharmaceutical Hormonal Drugs Description and Business Overview
6.15.3 Shandong Xinhua Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Xinhua Pharmaceutical Hormonal Drugs Product Portfolio
6.15.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.16 Huazhong Pharmaceutical
6.16.1 Huazhong Pharmaceutical Corporation Information
6.16.2 Huazhong Pharmaceutical Hormonal Drugs Description and Business Overview
6.16.3 Huazhong Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Huazhong Pharmaceutical Hormonal Drugs Product Portfolio
6.16.5 Huazhong Pharmaceutical Recent Developments/Updates
6.17 China Resources Zizhu Pharmaceutical
6.17.1 China Resources Zizhu Pharmaceutical Corporation Information
6.17.2 China Resources Zizhu Pharmaceutical Hormonal Drugs Description and Business Overview
6.17.3 China Resources Zizhu Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 China Resources Zizhu Pharmaceutical Hormonal Drugs Product Portfolio
6.17.5 China Resources Zizhu Pharmaceutical Recent Developments/Updates
6.18 Shanghai CP GENERAL Pharmaceutical
6.18.1 Shanghai CP GENERAL Pharmaceutical Corporation Information
6.18.2 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Description and Business Overview
6.18.3 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Portfolio
6.18.5 Shanghai CP GENERAL Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Lianhuan Pharmaceutical
6.19.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
6.19.2 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Description and Business Overview
6.19.3 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Portfolio
6.19.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormonal Drugs Industry Chain Analysis
7.2 Hormonal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormonal Drugs Production Mode & Process
7.4 Hormonal Drugs Sales and 麻豆原创ing
7.4.1 Hormonal Drugs Sales Channels
7.4.2 Hormonal Drugs Distributors
7.5 Hormonal Drugs Customers
8 Hormonal Drugs 麻豆原创 Dynamics
8.1 Hormonal Drugs Industry Trends
8.2 Hormonal Drugs 麻豆原创 Drivers
8.3 Hormonal Drugs 麻豆原创 Challenges
8.4 Hormonal Drugs 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
Roche
Novartis
Mitsubishi Tanabe Pharma Korea
Anhui Renhe Pharmaceutical
Shanghai ZhongHua Pharmaceutical Nantong
He'nan Xuchang Huaren Pharmaceutical
Wuhan Wujing Pharmaceutical
Harbin Pharmaceutical Group
Changzhou Siyao Pharmaceuticals
Hunan Wzt Pharmaceutical
Tianjin Tianyao Pharmaceutical
Henan Lihua Pharmaceutical
Hubei Tiansheng Pharmaceutica
Shandong Xinhua Pharmaceutical
Huazhong Pharmaceutical
China Resources Zizhu Pharmaceutical
Shanghai CP GENERAL Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
听
听
*If Applicable.